|
|
||||||||
a Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, the Netherlands
b Department of Pediatric Cardiology, Leiden University Medical Center, Leiden, the Netherlands
Accepted for publication November 9, 2007.
* Address correspondence to Dr Hoohenkerk, Anne de Vrieslaan 9, Amstelveen, 1187 WN, the Netherlands (Email: hoohenkerk{at}casema.nl).
Presented at the Poster Session of the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.
| Pediatric cardiac surgery:
The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal.
|
| Abstract |
|---|
|
|
|---|
Methods: Between 1979 and 2007, 20 consecutive patients underwent correction of atrioventricular septal defect and tetralogy of Fallot. Five patients had undergone prior palliative shunts. In all patients, a transatrial-transpulmonary approach was used and repair was accomplished without a conduit. The two-patch technique was used to correct the atrioventricular septal defect. Clinical data were obtained by retrospective review of inpatient and outpatient clinical charts.
Results: There was no in-hospital mortality and one late, noncardiac death. Six patients required eight reoperations, six for left atrioventricular valve insufficiency (repair: n = 4; replacement: n = 2), one for residual ventricular septal defect, and one for pulmonary artery branch obstruction. Follow-up was complete for all patients (median, 17 years; range, 1.5 to 28 years). All 19 survivors were in good clinical condition at last control, without medication, and in New York Heart Association class I (n = 18) or II (n = 1). Transesophageal echocardiography revealed good right ventricular function, low right ventricular outflow tract gradients (mean, 9 ± 7.4 mm Hg), and trace pulmonary valve insufficiency (n = 11).
Conclusions: Atrioventricular septal defect and tetralogy of Fallot can be repaired with low mortality by the transatrial-transpulmonary approach without the use of a conduit.
The combination of complete atrioventricular septal defect and tetralogy of Fallot (cAVSD-TOF) is a well-recognized congenital heart malformation [1–4]. Although surgical mortality has decreased in the last decade, postoperative complications such as residual ventricular septal defect, incompetence of the left atrioventricular (AV) valve, residual right ventricular outflow tract obstruction, and pulmonary regurgitation do occur and sometimes require reoperation [5, 6]. Concerning these complications, controversy exists about the best surgical approach [7–13]. This discussion is related to the use of a right ventriculotomy, cleft closure of the left AV valve, and the best way to reconstruct the right ventricular outflow tract [14]. Other controversies concern the use of palliative procedures and the timing of complete repair [15–18].
We evaluated our 28 years' experience with total correction of cAVSD-TOF, in which a transatrial-transpulmonary approach without a valved conduit was used in all patients.
| Patients and Methods |
|---|
|
|
|---|
|
Atrioventricular septal defect repair
A two-patch technique and a transatrial approach were used for AVSD repair in all patients. Different patches were used, including autologous pericardium (n = 5), xenograft pericardium (n = 3), or Dacron patch (n = 12). The left AV valve cleft was closed in 15 patients using interrupted sutures. Except for 2 patients, the coronary sinus was left draining into the right atrium.
Right ventricular outflow tract
Right ventricular outflow tract enlargement was performed by a transatrial-transpulmonary approach in all patients. Infundibular stenosis was relieved through the pulmonary valve in the absence of a valvular stenosis.
In the presence of a valvular obstruction, the valve was incised by extending the longitudinal incision in the pulmonary trunk. In all patients, the incision did not extend for more than 3 to 4 mm into the right ventricular myocardium. Whenever possible, the valve leaflets were spared by opening the pulmonary annulus through a commissure. Infundibulum obstruction was resected thereafter.
In all patients, a transannular patch was used. Transannular patches were intentionally kept small to avoid pulmonary insufficiency. Homografts or other valved conduits were not used.
Data Acquisition and Statistical Analysis
Patient data were collected by reviewing both inpatient and outpatient medical records, including operative lists, patient databases, hospital records, and cardiac catheterization and echocardiographic reports. Recent echocardiographic Doppler studies were present for all surviving patients. All data were compiled in a computerized data bank and analyzed with the statistical computing package SPSS 12.0.1 (SPSS Inc, Chicago, IL).
| Results |
|---|
|
|
|---|
Timing of Repair
The timing of correction of cAVSD-TOF has moved to earlier repair (Fig 1). An unpaired Student's t test revealed that mean age at repair before 1990 was significantly higher (34.6 ± 18.5 months) (p = 0.0001) compared with mean age at repair after 1990 (15.1 ± 11.9 months).
|
Reoperation
Six patients required eight reoperations. Four patients received one reoperation, and 2 patients had two reoperations. Median interval for the first reoperation was 1.8 years after initial repair (range, 4.5 months to 26 years). Only 2 patients underwent a reoperation within 1 year after initial repair. Left AV valve incompetence was the most frequent indication for reoperation (six of eight reoperations). In 3 patients, the cleft had not been closed at initial repair, and in 1 patient the valves had been noted to be dysplastic at first surgery. At first reoperation, the cleft of the left AV valve was closed in 3 patients, and an annuloplasty by plication of a lateral commissure was performed in 1 patient. In 1 patient in whom the left AV valve was observed to be dysplastic, replacement was necessary at first reoperation. In 1 patient who had two reoperations for left AV valve incompetence, the valve had to be replaced at the second reoperation.
Other indications for reoperation were residual ventricular septal defect (n = 2), residual or recurring right ventricular outflow tract obstruction (n = 2), branch pulmonary artery obstruction (n = 1), and pulmonary incompetence (n = 1). One patient required a pacemaker implantation after the second reoperation. There was no mortality related to reoperation. A summary of reoperation data per patient is given in Table 2.
|
|
| Comment |
|---|
|
|
|---|
Total correction of cAVSD-TOF remains a surgical challenge. Several factors are thought to contribute to morbidity and mortality after repair of cAVSD-TOF. These include AV valve incompetence, pulmonary valve incompetence, residual shunts, and right ventricular outflow tract obstruction.
Since 1969, more than 38 studies of complete cAVSD-TOF repair have been published. The majority of these studies consist of small patient groups, usually operated on with different surgical strategies and with short follow-up. In reports of earlier years, operative mortality was high, ranging from 29% to 40% [19–21]. During the last decade, reports have shown a reduction in mortality. The mortality rate of our series corresponds with the low mortality rate found in other more recent studies, in which the mortality ranged from 0% to 11% [22–25]. This improvement can be attributed to several factors, including perioperative transesophageal echocardiography and improved perioperative care. As in early reports, left AV valve incompetence remains a postoperative problem, probably owing to multifactor causes.
This study encompasses a single-institution experience in a period of 28 years. Our two-patch technique to repair cAVSD has not been changed throughout these years and is not different for cAVSD-TOF. The main complication has been residual or recurrent incompetence of the left AV valve for which reason 6 of 20 patients (30%) required reoperation. Residual left AV valve insufficiency occurred significantly more in the earlier years of our experience. Nonclosure of the cleft was the reason for reoperation in 3 patients, and important AV valve dysplasia had been noted in another patient. Dehiscence of a previously closed cleft occurred in 1 patient. It has been reported by others that initial closure of the cleft of the left AV valve prevents later reoperations [26, 27]. When reoperation is required, repair of the AV valve is possible in the majority of patients. Our current policy is to close the left AV valvular cleft in all cases. Discussion remains concerning the management of the right ventricular outflow tract in cAVSD-TOF. A right ventriculotomy allows a good exposure of the ventricular septal defect, and the infundibulum can be resected more easily than by a transatrial-transpulmonary approach. The potential drawbacks of a right ventriculotomy include postoperative ventricular dysfunction and late dysrhythmias. Retrospective reviews of dysrhythmia rates on transatrial-transpulmonary and RV approaches in cAVSD-TOF report an increased incidence of dysrhythmias associated with ventriculotomy [24, 28].
In our series, all patients were treated with a transatrial-transpulmonary approach. A transannular patch was used in all patients. Right ventricular failure and dysrhythmias were not observed during follow-up. Only 1 patient required a pacemaker. One of 20 patients required reoperation for pulmonary valve incompetence. The extent of incision in the right ventricular myocardium in the transatrial-transpulmonary approach is limited to no more than 3 to 4 mm proximal to the valve annulus. The ventricular septal defect can normally not be closed through this approach, and in our view the damage to the right ventricular myocardium is less than in a conventional right ventriculotomy.
In conclusion, our method of repair of cAVSD-TOF has so far been associated with no cardiac-related mortality and good functional outcome in all survivors. Left AV valve incompetence is a factor affecting the reoperation rate. The transatrial-transpulmonary approach can be used to manage the cAVSD-TOF with a limited reoperation rate. Our current policy is to correct cAVSD-TOF electively at an age between 6 and 12 months, the main reason being sufficiently sized pulmonary arteries. A modified Blalock shunt would be placed (by sternotomy) if important cyanosis or cyanotic spells occur neonatally or in early infancy.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
T. P. Graham Jr The Year in Congenital Heart Disease J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1492 - 1499. [Full Text] [PDF] |
||||
![]() |
C. D. Fraser Jr Invited commentary. Ann. Thorac. Surg., May 1, 2008; 85(5): 1690 - 1690. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |